Kuros Biosciences AG

SWX:KURN Stock Report

Market Cap: CHF 806.2m

Kuros Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KURN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,220,2328.51%
Institutions6,393,40716.9%
Individual Insiders9,028,84323.9%
General Public19,209,16350.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 49.25% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.9%
C. Oomen
8,299,433CHF 176.8m0%no data
4.64%
Hatstone Fund Services Limited
1,757,777CHF 37.4m0%no data
4.64%
Global Fund Advisors Limited, Asset Management Arm
1,754,946CHF 37.4m0%98.48%
3.86%
Aldabra B.V
1,462,455CHF 31.2m0%no data
3.32%
BlackRock, Inc.
1,257,834CHF 26.8m1,990%no data
2.92%
UBS Asset Management AG
1,104,870CHF 23.5m0%no data
2.79%
Medical Strategy GmbH, Asset Management Arm
1,056,504CHF 22.5m0%1.48%
1.93%
Clemens van Blitterswijk
729,410CHF 15.5m0%no data
1.58%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
599,272CHF 12.8m0%0.5%
0.48%
ZKB Asset Management
180,399CHF 3.8m-5.18%0.01%
0.31%
Zürcher Kantonalbank, Investment Arm
116,782CHF 2.5m4.85%0.02%
0.25%
Valiant Bank AG, Asset Management Arm
95,667CHF 2.0m46.3%0.21%
0.11%
Migrosbank Asset Management
41,461CHF 883.2k0%0.06%
0.11%
BCV Asset Management
40,000CHF 852.0k0%0.02%
0.075%
State Street Global Advisors, Inc.
28,400CHF 604.9k47.4%no data
0.06%
Pictet Asset Management SA
22,812CHF 485.9k48.5%no data
0.058%
The Vanguard Group, Inc.
22,133CHF 471.4k0%no data
0.058%
NFS Capital AG
22,000CHF 468.6k0%0.18%
0.033%
Swiss Rock Asset Management AG
12,500CHF 266.2k0%0.03%
0.026%
INTERSELECT NV
10,000CHF 213.0k0%1.75%
0.022%
Lombard Odier Asset Management (Switzerland) SA
8,219CHF 175.0k0%no data
0.018%
Union Bancaire Privee, CBI-TDB, Asset Management Arm
6,985CHF 148.8k0%no data
0.016%
Baloise Asset Management
6,204CHF 132.1k0%0.01%
0.013%
Vogt Asset Management Trust Reg.
4,775CHF 101.7k0%0.09%
0.0031%
ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg
1,182CHF 25.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/27 09:08
End of Day Share Price 2025/01/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kuros Biosciences AG is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laura Pfeifer-RossiBank am Bellevue
Olav ZilianMirabaud Securities Limited
Dylan van HaaftenNIBC Bank N.V.